This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Hospitals Face New Superbug Liabilities

ORANGEBURG, N.Y., Feb. 10, 2014 (GLOBE NEWSWIRE) -- Superbugs. Nightmare Bacteria. Antibiotic Resistant Strains. No matter what you call it, it's bad news for hospitals, which face increasingly stringent financial penalties under the Affordable Care Act. Specifically, patient readmissions and follow-up diagnostics due to hospital-acquired infections are increasingly not covered for reimbursement depending on the hospital's track record and other associated factors.

"When a breach in the sterile technique for conventional endoscopes is discovered, all routine endoscopies are cancelled and patients that received endoscopic procedures are notified, tested, and treated if need be," says Dr. Daniel R. Cottam, M.D., of the Bariatric Medicine Institute.

It's a perfect storm for hospitals, such as the one reported last month in Illinois that had 44 newly reported cases of "Nightmare Bacteria" acquired from endoscopic procedures despite correct cleaning of the endoscopes.

Dr. Cottam goes on to explain, "It's a process that can close an endoscopic unit for several weeks. Not only must hospitals assume the additional cost for non-reimbursed patient care, but the shutdown interferes with providing everyday healthcare and can result in patients losing confidence in the hospital."

Vision-Sciences, Inc.'s (Nasdaq:VSCI) EndoSheath® Technology is a cost-effective and patented solution for patients, doctors, hospitals, and other medical facilities. It is the only endoscopic technology with a sterile barrier and 3-step, 10-minute cleaning process. It eliminates the need for what the industry calls "High Level Disinfection" following each use – a complicated 27-step, 45-minute disinfection process that relies on zero human error to ensure a patient-ready device.

"There has never been a better time for the healthcare industry to make EndoSheath Technology standard use in endoscopies. We feel patients should always get a sterile device and we are so confident in this technology that we are making it available to all endoscopic manufacturers that want it," said Lewis C. Pell, Chairman and Co-founder of Vision-Sciences.

With the FDA cleared EndoSheath Technology, an endoscope is placed inside a new, sterile sheath for each endoscopy. The sheath is discarded after each procedure, guarding against the use of a dirty endoscope with the risk of bacterial or viral cross-contamination to the next patient.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs